NxStage

NxStage is a medical device company that develops, manufactures, and markets products for the treatment of end-stage renal disease and acute kidney failure. NxStage also provides the critical care market with a portfolio of products for blood filtration and removal of excess fluids and toxins.

History

NxStage was founded in 1998 with the goal of developing a practical home hemodialysis system. The company's first product, the NxStage System One, was cleared by the FDA in 2005. In 2017, NxStage was acquired by Fresenius Medical Care, a global provider of kidney dialysis services and renal care products.

Products

NxStage's primary product is the System One, a portable hemodialysis system. The System One is designed to provide the flexibility and convenience of hemodialysis at home, while maintaining the high-quality treatment associated with in-center dialysis. The company also offers the PureFlow SL, a dialysis fluid preparation system, and a range of dialyzers and bloodlines.

Clinical Studies

NxStage has conducted numerous clinical studies to demonstrate the safety and efficacy of its products. These studies have shown that more frequent home hemodialysis with the System One can improve patient outcomes, including survival, hospitalization rates, and quality of life.

See Also

• Hemodialysis
• Fresenius Medical Care
• Kidney failure
• End-stage renal disease

References

<references />

External Links

• Official Website

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia